| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/10/2006 | CN1768786A Wind-dispelling wine for bone disease |
| 05/10/2006 | CN1768758A Soft capsule of medicinal composition and its preparation method |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255405C Substituted pyrazoles |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255172C Medical paste for rheumatism and bone ache |
| 05/10/2006 | CN1255169C Medicine for relaxing muscles and tendons and activating collaterals and dispelling pain |
| 05/10/2006 | CN1255152C Chinese patent medicine for treating bone fracture |
| 05/10/2006 | CN1255150C Chinese medicine preparation for curing hyperosteogeny and its preparation method |
| 05/10/2006 | CN1255143C Externally applied Chinese traditional medicinal wine and its preparing method |
| 05/10/2006 | CN1255139C Prepared Chinese internal medicine for treating hyperosteogeny |
| 05/10/2006 | CN1255126C Medicinal prescription for treating aseptic necrosis of femur head |
| 05/10/2006 | CN1255125C Chinese medicine formulation with functions of resisting senescence and preventing and treating posteoporosis and cerebral lesion |
| 05/10/2006 | CN1255113C Cell growth regulating factor D and its preparation process |
| 05/10/2006 | CN1255112C Cell growth regulating factor E and its preparation process |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041703 Particularly septic shock and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained |
| 05/09/2006 | US7041699 Ascorbic compound; L-lysine compound; c) L-proline compound; and d) epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, or catechin; blocking cancer proliferation and metastasis. |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041686 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/09/2006 | US7041645 Methods of inhibiting or inducing bone formation |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2346662C Compositions containing diphosphonic acids |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/04/2006 | WO2006047354A1 Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-jun n terminal kinases (jnk) and p-38 kinases |
| 05/04/2006 | WO2006047317A1 Pyrrolotriazine compounds |
| 05/04/2006 | WO2006046910A1 Novel use |
| 05/04/2006 | WO2006046569A1 Neuronal differentiation promoting peptide |
| 05/04/2006 | WO2006046100A1 Pharmaceutical composition of alendronic acid |
| 05/04/2006 | WO2006045870A1 Orally-dispersible pharmaceutical compositions |
| 05/04/2006 | WO2006045578A2 Process for the preparation of ibandronate |
| 05/04/2006 | WO2006017456A3 Chymopapain isoenzymes, compositions, and uses thereof |
| 05/04/2006 | WO2006007378A3 Pyrrolotriazine kinase inhibitors |
| 05/04/2006 | WO2006003290A3 Sulphated depolymerised derivatives of exopolysaccharides (eps), preparation and uses thereof |
| 05/04/2006 | WO2006003289A3 Sulphated polysaccharide derivatives for modulating angiogenesis |
| 05/04/2006 | WO2006002348A3 Solid and crystalline ibandronic acid |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094711 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/04/2006 | US20060094710 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 05/04/2006 | US20060094667 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 05/04/2006 | US20060094013 Salt-inducible kinases 2 and use thereof |
| 05/04/2006 | US20060093651 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2006 | US20060093619 Medicament for prevention and treatment of bone fracture and osteoporosis |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093602 Inflammatory mediator antagonists |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | CA2580475A1 Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-jun n terminal kinases (jnk) and p-38 kinases |
| 05/03/2006 | EP1652856A1 Stress proteins-derived peptides and method of use thereof |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652527A1 Accelerator for mineral absorption and use thereof |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1651638A1 Pyridyl piperazinyl ureas |
| 05/03/2006 | EP1651636A1 Substituted heterocyclic diarylamine analogues |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/03/2006 | EP1651253A1 Connective tissue derived polypeptides |
| 05/03/2006 | EP1651249A1 Use of calcitonin in osteoarthritis |
| 05/03/2006 | EP1651238A1 Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss |
| 05/03/2006 | EP1651205A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1236044B1 Diagnosing and treating arthritic disorders |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | CN2776403Y Anti inflammation pain relieving plaster |
| 05/03/2006 | CN1768069A Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1767824A Photostabilized topical formulations of KETOPROFEN |
| 05/03/2006 | CN1765931A GLP-1 fusion protein and its preparation method and medicinal uses |
| 05/03/2006 | CN1765361A Novel bulleyaconitine A powder injection and its production method |
| 05/03/2006 | CN1254486C Synthesis and expression of recombinant human parathyroxin gene |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 05/03/2006 | CN1254465C Calcilytic compounds |
| 05/03/2006 | CN1254269C 'Bingshe' antalgesic plaster |
| 05/03/2006 | CN1254264C Chinese traditional medicine for treating rheumatoid arthritis, and preparing technique |
| 05/02/2006 | US7038061 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038045 Pyrazolotriazines as kinase inhibitors |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |